Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), ...

Friday brought more bad news for the healthcare sector as the economic outlook darkened. The losses crossed subsectors, hitting insurers, drug developers and equipment makers. Boston Scientific, ...

Shares of Danaher Corp. DHR slipped 8.15% to $181.77 Friday, on what proved to be an all-around poor trading session for the ...

DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

Partners in Financial Planning has jumped into Danaher with a $433,000 stake, joining a chorus of institutions reshuffling ...

Danaher Corp. closed 29.75% below its 52-week high of $281.70, which the company achieved on August 1st.

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

Allianz SE just injected $8.4 million worth of confidence into Danaher, snagging over 36,000 shares in the fourth quarter.

RBC Capital analyst Conor McNamara maintained a Buy rating on Danaher (DHR – Research Report) on April 1 and set a price target of $270.00. The ...

Out of all of the options we uncovered, 15 are puts, for a total amount of $1,238,077, and there was 1 call, for a total ...

Damien McDonald appointed CEO, effective as of May 12, 2025 Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, ...